|
Volumn 344, Issue 5, 2011, Pages 311-319
|
Synthesis of 2-mercaptobenzimidazole derivatives as potential anti-microbial and cytotoxic agents
|
Author keywords
1,3,4 Oxadiazole; 4 Thiazolidinone; Antibacterial; Antifungal; Cytotoxicity
|
Indexed keywords
2 (5 CHLORO PHENYL [1,3,4] OXADIAZOLE 2 YLMETHYLSULFANYL) 1H BENZIMIDAZOLE;
2 (5 PHENYL [1,3,4] OXADIAZOLE 2 YLMETHYLSULFANYL) 1H BENZIMIDAZOLE;
2 (5 PYRIDIN 3 YL[1,3,4]OXADIAZOLE 2 YLMETHYLSULFANYL] 1H BENZIMIDAZOLE;
2 [5 (2 CHLORO 4 NITRO PHENYL)[1,3,4]OXADIAZOLE 2 YLMETHYLSULFANYL] 1H BENZIMIDAZOLE;
2 [5 (4 NITRO PHENYL)[1,3,4]OXADIAZOLE 2 YLMETHYLSULFANYL] 1H BENZIMIDAZOLE;
2 BENZIMIDAZOLETHIOL DERIVATIVE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (2 HYDROXY 3 METHOXY PHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (2 HYDROXYPHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (3 HYDROXYNAPHTHALEN 2 YL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (4 AMINEPHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (4 CHLOROPHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (4 HYDROXYPHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 (4 METHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 4 TOLYLTHIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 FURAN 2 YLTHIAZOLIDIN 4 ONE;
3 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL) 2 PHENYLTHIAZOLIDIN 4 ONE;
3 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL] NAPHTHALEN 2 OL;
4 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL]PHENOL;
4 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL]PHENYLAMINE;
5 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL] BENZENE 1,2,3 TRIOL;
6 [5 (1H BENZIMIDAZOL 2 YLSULFANYLMETHYL)[1,3,4]OXADIAZOLE 2 YL]NAPHTHALENE 1,7 DIOL;
ALDEHYDE;
BENZOIC ACID;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIFUNGAL ACTIVITY;
ARTEMIA;
ARTICLE;
ASPERGILLUS FUMIGATUS;
BIOASSAY;
CANDIDA ALBICANS;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SCREENING;
DRUG SYNTHESIS;
ENTEROCOCCUS FAECALIS;
ESCHERICHIA COLI;
IN VITRO STUDY;
INFRARED SPECTROSCOPY;
KLEBSIELLA PNEUMONIAE;
MASS SPECTROMETRY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
STAPHYLOCOCCUS AUREUS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIFUNGAL AGENTS;
ARTEMIA;
BENZIMIDAZOLES;
FUNGI;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
MICROBIAL SENSITIVITY TESTS;
|
EID: 79955448608
PISSN: 03656233
EISSN: 15214184
Source Type: Journal
DOI: 10.1002/ardp.200900291 Document Type: Article |
Times cited : (30)
|
References (31)
|